Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Heartflow reports significant revenue growth as CCTA sees wider adoption
The company keeps gaining momentum thanks to the success of its AI-powered imaging software.
Bill in Congress would rein in PBMs, force divestment from pharmacies
The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.
CMS pauses new Medicare hospice and home health provider entries for six months
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.
Consolidation of physician practices proceeds apace, corporatizing medicine one acquisition at a time
The days when most doctors worked in independent practice settings are fading from memory like old photoprints in a musty scrapbook.
Investor-bought PCPs carry on like nothing much has changed—with caveats
Private-equity acquisitions of primary-care provider practices neither alter hospitalization rates nor affect acute-care outcomes, according to new research out of Brown University.

Johnson & Johnson’s HIV vaccine trial fails

Johnson & Johnson has discontinued its Mosaico clinical trial that aimed to protect against HIV after its Phase 3 study revealed the regiment was safe but ineffective.

Imaging industry names in the news: Canon, Medality, Viz.ai, more

Promaxo Inc. of Oakland, Calif., sold eight of its systems for performing AI-equipped, MRI-guided prostate interventions in the fourth quarter of 2022. The company launched a year prior and has now topped $15 million in sales.

Fysicon’s QMAPP Hemodynamic Monitoring Device

Canon Medical Systems announces new partnership focused on enterprise imaging and hemodynamics

The partnership is with ScImage, a California-based healthcare technology company known for its extensive EI background.

Groups clash with CMS over independent dispute resolution

The heads of RBMA and three other medical management associations are locking arms and pointing their voices in the general direction of Washington.

M&A mergers and acquisitions business deal

GE HealthCare eyes IR guidance company, releases revenue results

Less than a week after ringing the Nasdaq opening bell to showcase its long-awaited independence, GE HealthCare has announced a first strategic acquisition is in the works.

Autonomous radiology stalwart taking health insurance internal

The independent-practice coalition Strategic Radiology has founded a captive health insurance program to offer its 1,500 or so member physicians and their respective support staffs.

GE HealthCare hires former Amazon, FDA exec to oversee science and technology operations

A med-tech leader of note is taking skills refined at Amazon, the FDA and the CDC to GE HealthCare, where he will serve as the newly independent company’s first CTO.

Imaging industry names in the news: GE HealthCare, OncoNano, NeuroLogica, NorthStar Medical Radioisotopes and Inhibrx

GE HealthCare has begun trading as an independent company on the Nasdaq exchange. To mark the occasion and showcase its completed spinoff from General Electric, the company remotely rang the opening bell at Nasdaq from its manufacturing facility in Waukesha, Wis.

Business Intelligence

Heartflow reports significant revenue growth as CCTA sees wider adoption

Bill in Congress would rein in PBMs, force divestment from pharmacies

CMS pauses new Medicare hospice and home health provider entries for six months

Consolidation of physician practices proceeds apace, corporatizing medicine one acquisition at a time

Investor-bought PCPs carry on like nothing much has changed—with caveats